WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• TET2 dioxygenase regulates cell identity and suppresses tumorigenesis by modulating DNA methylation and gene expression.
• The recruitment mechanism of TET2 to specific genomic sites, similar to other chromatin-modifying enzymes, remains largely unknown.
• WT1, a transcription factor, exhibits mutually exclusive mutations with TET2, IDH1, and IDH2 in acute myeloid leukemia (AML).

Purpose of the Study:

• To elucidate the mechanism by which TET2 is recruited to specific genomic sites.
• To investigate the functional relationship between WT1 and TET2 in the context of acute myeloid leukemia.
• To explain the observed mutual exclusivity of WT1 and TET2 mutations in AML.

Main Methods:

• Co-immunoprecipitation assays to demonstrate physical interaction between WT1 and TET2.
• Gene expression analysis to assess the impact of WT1-TET2 interaction on target gene activation.
• Cell proliferation and colony formation assays to evaluate the functional consequences of TET2 activity dependent on WT1.

Main Results:

• WT1 physically interacts with and recruits TET2 to its target genes, thereby activating their expression.
• AML-derived TET2 mutations disrupt the interaction between WT1 and TET2.
• TET2 suppresses leukemia cell proliferation and colony formation in a WT1-dependent manner.
• The study identified a mechanism for targeting TET2 to specific DNA sequences via WT1.

Conclusions:

• WT1 acts as a crucial recruiter of TET2 to specific genomic loci, influencing gene expression and DNA methylation.
• The findings provide a mechanistic explanation for the mutual exclusivity of WT1 and TET2 mutations in AML.
• A novel IDH1/2-TET2-WT1 pathway is suggested to play a role in suppressing AML development.